Clinical trial
A Multicenter, Parallel, Blinded, Randomized Comparison of the Safety and Efficacy of Balloon Angioplasty Plus Intraluminal SBCV To Balloon Angioplasty Alone for Treatment of Stenosis or Occlusion Within the Femoropopliteal Artery
NCT02568293 is registered in ClinicalTrials.gov with Symic Vascular as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Multicenter, Parallel, Blinded, Randomized Comparison of the Safety and Efficacy of Balloon Angioplasty Plus Intraluminal SBCV To Balloon Angioplasty Alone for Treatment of Stenosis or Occlusion Within the Femoropopliteal Artery
- Lead sponsor
- Symic Vascular
- Phase
- Not applicable
- Overall status
- Unknown status
- Start date
- October 31, 2015
- Completion date
- October 31, 2017
- Enrollment
- 66 (estimated)
- Sites
- 8
Conditions
As the registry lists them; a condition with its own page is linked.